International Conference on Cancer Research and Development

Welcome to the International Conference on Cancer Research and Development (Cancer R&D 2026), a prestigious three-day congress dedicated to advancing the field of basic, preclinical, and translational cancer research. Hosted by the United Scientific Group, a distinguished non-profit organization committed to the progression of cancer research, Cancer R&D serves as a platform to foster innovation, cultivate knowledge, and encourage meaningful connections and collaborations within the global cancer research community. This event will showcase the latest findings and novel approaches in cancer research, with a focus on topics such as early cancer detection, computational biology and AI in cancer, cancer immunotherapies, novel drug development, and advances in organ-specific cancer research. Notable sessions will also include discussions on Non-Small Cell Lung Cancer, providing attendees with a comprehensive overview of current challenges and advancements in the field.Among the highlights of the conference, Prof. Raghu Kalluri will be honored with the Lifetime Achievement Award for his relentless dedication and transformative research on the extracellular matrix, which has advanced therapies for cancer, autoimmune disorders, genetic diseases, and organ fibrosis. This recognition underscores the importance of collaboration and innovation in cancer research, as the previous ten editions of the Cancer R&D conference have successfully brought together over 1,050 researchers from leading institutes and organizations. The conference aims to create a foundational trust among participants, fostering a collaborative environment where researchers can share insights and ideas. Attendees will have the opportunity to network face-to-face, building rapport with fellow researchers and establishing connections that can lead to fruitful collaborations. The Cancer R&D 2026 conference promises to be an informative experience, offering a platform for researchers to present their work and gain new insights in the ever-evolving field of cancer research.